Aclaris Therapeutics, Inc. financial data

Symbol
ACRS on Nasdaq
Industry
Pharmaceutical Preparations
Location
701 Lee Road, Suite 103, Wayne, PA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 6, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 601 % -19.2%
Debt-to-equity 27 % -15.9%
Return On Equity -26.3 % +59.3%
Return On Assets -20.7 % +57.6%
Operating Margin -171 % +70.1%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 71.4M shares +0.84%
Common Stock, Shares, Outstanding 71.4M shares +0.85%
Entity Public Float 713M USD -20.7%
Common Stock, Value, Issued 1K USD 0%
Weighted Average Number of Shares Outstanding, Basic 71.4M shares +0.81%
Weighted Average Number of Shares Outstanding, Diluted 71.4M shares +0.81%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 27.1M USD +26.4%
Cost of Revenue 2.81M USD -21.3%
Research and Development Expense 51.2M USD -44.8%
General and Administrative Expense 25.5M USD -18.8%
Costs and Expenses 73.4M USD -49%
Operating Income (Loss) -46.3M USD +62.2%
Nonoperating Income (Expense) 2.89M USD +24.6%
Net Income (Loss) Attributable to Parent -37M USD +67.7%
Earnings Per Share, Basic -0.52 USD/shares +68.7%
Earnings Per Share, Diluted -0.52 USD/shares +68.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 47.7M USD +22.1%
Cash, Cash Equivalents, and Short-term Investments 173M USD -7.27%
Accounts Receivable, after Allowance for Credit Loss, Current 343K USD -0.87%
Assets, Current 132M USD +7.53%
Property, Plant and Equipment, Net 1.13M USD -35.8%
Intangible Assets, Net (Excluding Goodwill) 269K USD -96.1%
Other Assets, Noncurrent 3.22M USD +20.9%
Assets 182M USD -16.5%
Accounts Payable, Current 7.66M USD -20.6%
Employee-related Liabilities, Current 2.6M USD -47.6%
Accrued Liabilities, Current 4.72M USD -68.9%
Contract with Customer, Liability, Current 3.77M USD
Liabilities, Current 18.8M USD -31.1%
Contract with Customer, Liability, Noncurrent 21.2M USD
Deferred Income Tax Liabilities, Net 367K USD 0%
Operating Lease, Liability, Noncurrent 2.25M USD +22.4%
Other Liabilities, Noncurrent 2.25M USD +22.4%
Liabilities 52.2M USD -15.8%
Accumulated Other Comprehensive Income (Loss), Net of Tax 427K USD
Retained Earnings (Accumulated Deficit) -806M USD -4.81%
Stockholders' Equity Attributable to Parent 130M USD -16.7%
Liabilities and Equity 182M USD -16.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -20.8M USD +21%
Net Cash Provided by (Used in) Financing Activities 30M USD -70.2%
Net Cash Provided by (Used in) Investing Activities 16.8M USD -34.8%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 71.4M shares +0.85%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -4.04M USD -627%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 47.7M USD +22.1%
Deferred Tax Assets, Valuation Allowance 195M USD +5.65%
Deferred Tax Assets, Gross 197M USD +4.9%
Operating Lease, Liability 2.71M USD +26.4%
Depreciation 800K USD +14.3%
Payments to Acquire Property, Plant, and Equipment 135K USD -75.6%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -35.4M USD +69%
Lessee, Operating Lease, Liability, to be Paid 4.6M USD +57.7%
Property, Plant and Equipment, Gross 5.81M USD -8.72%
Operating Lease, Liability, Current 465K USD +50%
Lessee, Operating Lease, Liability, to be Paid, Year Two 847K USD +147%
Lessee, Operating Lease, Liability, to be Paid, Year One 766K USD -16.6%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.1M USD +65.9%
Lessee, Operating Lease, Liability, to be Paid, Year Three 868K USD +147%
Deferred Tax Assets, Operating Loss Carryforwards 119M USD -1.16%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 890K USD +147%
Additional Paid in Capital 936M USD +1%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 75K USD 0%
Depreciation, Depletion and Amortization 243K USD +22.7%
Share-based Payment Arrangement, Expense 9.26M USD -61.6%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%